Evidence map›Paper›PMID 36421280›Full record

ReviewAntibiotics (Basel, Switzerland)2022

Antimicrobial and Cell-Penetrating Peptides: Understanding Penetration for the Design of Novel Conjugate Antibiotics.

Andreas Hadjicharalambous, Nikolaos Bournakas, Hector Newman, Michael J Skynner, Paul Beswick

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Antimicrobial Peptide CPP-C3M4 AttenuatesAnimals : an open access journal from MDPI · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Andreas HadjicharalambousDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1QN, UK.ORCID 0000-0001-8310-5083
Nikolaos BournakasBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, UK.
Hector NewmanBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, UK.
Michael J SkynnerBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, UK.ORCID 0000-0001-6586-9055
Paul BeswickBicycleTx Limited, Portway Building, Granta Park, Cambridge CB21 6GS, UK.
Bicycle Therapeutics (United Kingdom) · GBUniversity of Cambridge · GBUniversity of Warwick · GB

Funding

Innovate UK 82975Medical Research Council 2496663Medical Research Council MR/W003554/1
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are short oligopeptides that can penetrate the bacterial inner and outer membranes. Together with cell-penetrating peptides (CPPs), they are called membrane active peptides; peptides which can translocate across biological membranes. Over the last fifty years, attempts have been made to understand the molecular features that drive the interactions of membranes with membrane active peptides. This review examines the features of a membrane these peptides exploit for translocation, as well as the physicochemical characteristics of membrane active peptides which are important for translocation. Moreover, it presents examples of how these features have been used in recent years to create conjugates consisting of a membrane active peptide, called a "vector", attached to either a current or novel antibiotic, called a "cargo" or "payload". In addition, the review discusses what properties may contribute to an ideal peptide vector able to deliver cargoes across the bacterial outer membrane as the rising issue of antimicrobial resistance demands new strategies to be employed to combat this global public health threat.

Indexed as

antimicrobial peptidesantimicrobial resistancecell membrane penetrationcell-penetrating peptidesmembrane active peptidesmembrane characteristicsnovel antibioticspeptide-antibiotic conjugatespeptide characteristics

Identifiers

PMID36421280
PMCPMC9686638
OpenAlexW4309606529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.